OPK
Income statement / Annual
Last year (2025), Opko Health Inc's total revenue was $606.88 M,
a decrease of 14.90% from the previous year.
In 2025, Opko Health Inc's net income was -$225.68 M.
See Opko Health Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$606.88 M |
$713.14 M |
$863.50 M |
$1.00 B |
$1.77 B |
$1.44 B |
$901.94 M |
$990.30 M |
$966.01 M |
$1.22 B |
| Cost of Revenue |
$478.83 M
|
$402.11 M
|
$545.37 M
|
$715.98 M
|
$1.19 B
|
$894.41 M
|
$572.48 M
|
$604.60 M
|
$620.13 M
|
$611.50 M
|
| Gross Profit |
$128.05 M
|
$311.03 M
|
$318.13 M
|
$288.22 M
|
$581.52 M
|
$541.01 M
|
$329.45 M
|
$385.70 M
|
$345.88 M
|
$610.20 M
|
| Gross Profit Ratio |
0.21
|
0.44
|
0.37
|
0.29
|
0.33
|
0.38
|
0.37
|
0.39
|
0.36
|
0.5
|
| Research and Development Expenses |
$124.03 M
|
$105.21 M
|
$89.59 M
|
$73.89 M
|
$76.85 M
|
$75.32 M
|
$117.87 M
|
$135.69 M
|
$126.44 M
|
$113.87 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$223.00 M
|
$304.22 M
|
$300.56 M
|
$372.67 M
|
$468.86 M
|
$355.57 M
|
$343.31 M
|
$358.40 M
|
$414.63 M
|
$490.90 M
|
| Other Expenses |
$0.00
|
$53.66 M
|
$85.00 M
|
$67.91 M
|
$17.07 M
|
$52.40 M
|
$142.33 M
|
$72.90 M
|
$81.26 M
|
$0.00
|
| Operating Expenses |
$347.04 M
|
$463.10 M
|
$475.15 M
|
$514.47 M
|
$562.77 M
|
$483.29 M
|
$603.50 M
|
$551.90 M
|
$625.74 M
|
$602.56 M
|
| Cost And Expenses |
$825.86 M
|
$865.21 M
|
$1.02 B
|
$1.23 B
|
$1.76 B
|
$1.38 B
|
$1.18 B
|
$1.16 B
|
$1.25 B
|
$1.21 B
|
| Interest Income |
$14.81 M
|
$8.43 M
|
$3.98 M
|
$1.98 M
|
$28.00 K
|
$152.00 K
|
$1.71 M
|
$1.24 M
|
$610.00 K
|
$478.00 K
|
| Interest Expense |
$108.46 M
|
$47.47 M
|
$13.51 M
|
$12.06 M
|
$18.88 M
|
$21.93 M
|
$21.52 M
|
$11.89 M
|
$6.60 M
|
$7.43 M
|
| Depreciation & Amortization |
$91.63 M
|
$98.18 M
|
$105.30 M
|
$108.66 M
|
$78.72 M
|
$85.36 M
|
$93.81 M
|
$97.34 M
|
$102.09 M
|
$96.58 M
|
| EBITDA |
-$41.30 M |
$135.28 M |
-$65.52 M |
-$270.81 M |
$83.57 M |
$155.98 M |
-$189.64 M |
-$68.04 M |
-$163.23 M |
$7.18 M |
| EBITDA Ratio |
-0.07
|
0.19
|
-0.08
|
-0.27
|
0.05
|
0.11
|
-0.21
|
-0.07
|
-0.17
|
0.01
|
| Operating Income Ratio |
-0.36
|
-0.21
|
-0.18
|
-0.23
|
0.01
|
0.04
|
-0.3
|
-0.17
|
-0.29
|
-0.06
|
| Total Other Income/Expenses Net |
-$22.41 M
|
$141.70 M
|
-$27.41 M
|
-$165.65 M
|
-$33.40 M
|
-$9.51 M
|
-$30.91 M
|
-$6.07 M
|
$4.52 M
|
-$271.00 K
|
| Income Before Tax |
-$241.39 M
|
-$10.36 M
|
-$184.43 M
|
-$391.90 M
|
-$14.65 M
|
$48.20 M
|
-$304.97 M
|
-$177.27 M
|
-$271.92 M
|
-$73.50 M
|
| Income Before Tax Ratio |
-0.4
|
-0.01
|
-0.21
|
-0.39
|
-0.01
|
0.03
|
-0.34
|
-0.18
|
-0.28
|
-0.06
|
| Income Tax Expense |
-$15.71 M
|
$42.84 M
|
$4.44 M
|
-$63.50 M
|
$15.49 M
|
$17.62 M
|
$7.06 M
|
-$38.70 M
|
$18.86 M
|
-$56.10 M
|
| Net Income |
-$225.68 M
|
-$53.22 M
|
-$188.86 M
|
-$328.41 M
|
-$30.14 M
|
$30.59 M
|
-$314.93 M
|
-$153.04 M
|
-$305.25 M
|
-$48.36 M
|
| Net Income Ratio |
-0.37
|
-0.07
|
-0.22
|
-0.33
|
-0.02
|
0.02
|
-0.35
|
-0.15
|
-0.32
|
-0.04
|
| EPS |
-0.3 |
-0.0767 |
-0.25 |
-0.46 |
-0.0455 |
0.0477 |
-0.53 |
-0.27 |
-0.55 |
-0.05 |
| EPS Diluted |
-0.3 |
-0.0767 |
-0.25 |
-0.46 |
-0.0455 |
0.0477 |
-0.53 |
-0.27 |
-0.55 |
-0.05 |
| Weighted Average Shares Out |
$751.13 M
|
$694.02 M
|
$751.77 M
|
$719.06 M
|
$648.08 M
|
$640.66 M
|
$595.45 M
|
$563.14 M
|
$555.00 M
|
$507.83 M
|
| Weighted Average Shares Out Diluted |
$751.13 M
|
$694.02 M
|
$751.77 M
|
$719.06 M
|
$648.08 M
|
$640.66 M
|
$595.45 M
|
$566.67 M
|
$559.16 M
|
$502.00 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
